Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dolutegravir + Lamivudine in Antiretroviral Treatment-naive Adults With HIV-1 Infection in a Multicenter Real-life Cohort Study

NCT04638686 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz as lead sponsor.

NCT NCT04638686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04638686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dolutegravir + Lamivudine in Antiretroviral Treatment-naive Adults With HIV-1 Infection in a Multicenter Real-life Cohort Study
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Phase
Observational
Overall status
Completed
Start date
June 15, 2020
Completion date
March 31, 2022
Enrollment
185 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection